Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human DDT Protein, N-His

Catalog #:   YHD86501 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P30046
Protein length: Pro2-Leu118
Overview

Catalog No.

YHD86501

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Pro2-Leu118

Predicted molecular weight

14.89 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P30046

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

DDT, D-dopachrome decarboxylase, Phenylpyruvate tautomerase II, D-dopachrome tautomerase

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human DDT protein
References

Exploring the interface between quantum biology, microwave technology, and neuroscience., PMID:40513771

Engineered noncanonical amino acids-based hydrogels for biomedical applications., PMID:40494491

Sustainability by design for recombinant protein therapeutics., PMID:40480466

The multifaced role of the macrophage-migration-inhibitory-factor (MIF)-family in organ fibrosis., PMID:40445596

Cryo-EM Structures of Apo and DDT-Bound P-Glycoprotein in Yellowfin Tuna., PMID:40439033

Impact of Vgsc-1014 mutations on the feeding pattern of Phlebotomus argentipes., PMID:40435187

The DNA damage tolerance factor Rad5 and telomere replication., PMID:40418329

A review of the efficacy of prostate cancer therapies against castration-resistant prostate cancer., PMID:40409404

Fexaramine as the intestine-specific farnesoid X receptor agonist: A promising agent to treat obesity and metabolic disorders., PMID:40409402

Computational methods for modeling protein-protein interactions in the AI era: Current status and future directions., PMID:40398752

Influence of Traditional Vanilla Curing on Its Physicochemical Properties and Aromatic Profile., PMID:40361735

MTHFD2: A significant mitochondrial metabolic enzyme and a novel target for anticancer therapy., PMID:40348077

PROTAC 2.0: Expanding the frontiers of targeted protein degradation., PMID:40348076

NLRP3 inflammasome: From drug target to drug discovery., PMID:40345614

Allelic variation in a cluster of epsilon glutathione S-transferase genes contributes to DDT and pyrethroid resistance in the major African malaria vector Anopheles funestus., PMID:40335906

Novel mechanisms underlying rapid-acting antidepressants: ketamine-like compounds, neurosteroid GABAkines, and psychedelics., PMID:40320133

Advancing atherosclerosis treatment: Drug encapsulation nanosystems and synthetic HDL nanoparticles., PMID:40320132

The role of cyclic adenosine monophosphate (cAMP) in pathophysiology of fibrosis., PMID:40318753

Gemcitabine and miRNA34a mimic codelivery with magnetic nanoparticles enhanced anti-tumor effect against pancreatic cancer., PMID:40306578

Targeting FLT3 for treating diseases: FLT3 inhibitors., PMID:40288485

An overview of progress in human metapneumovirus (hMPV) research: Structure, function, and therapeutic opportunities., PMID:40286981

Advances in artificial intelligence-envisioned technologies for protein and nucleic acid research., PMID:40252991

The Yeast HMGB Protein Hmo1 Is a Multifaceted Regulator of DNA Damage Tolerance., PMID:40244093

PCNA encircling primer/template junctions is eliminated by exchange of RPA for Rad51: Implications for the interplay between human DNA damage tolerance pathways., PMID:40236028

Selective imaging probes for differential detection of pathological tau polymorphs in tauopathies., PMID:40216294

The spindle assembly checkpoint: Molecular mechanisms and kinase-targeted drug discovery., PMID:40216293

Therapeutic potential of targeting ubiquitin-specific proteases in colorectal cancer., PMID:40216291

Pathogenic TDP-43 in amyotrophic lateral sclerosis., PMID:40188980

Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery., PMID:40180310

Transcription Activator FgDDT Interacts With FgISW1 to Regulate Fungal Development and Pathogenicity in the Global Pathogen Fusarium graminearum., PMID:40151047

Emerging role of deubiquitinases in modulating cancer chemoresistance., PMID:40118446

Tubulin targeting agents and their implications in non-cancer disease management., PMID:40118444

On-demand dual-stimuli-responsive hydrogels for localized and sustained delivery of MP-L [I5R8] to treat bacterial wound infections., PMID:40117802

IRE1α-mediated UPR activation in gastrointestinal cancers: Adaptive mechanisms and therapeutic potential., PMID:40097091

Identification and Characterization of the Structure and Size of Aβ42 Oligomers Targeting the Receptor FcγRIIb., PMID:40094208

Epigenetic code underlying EGFR-TKI resistance in non-small cell lung cancer: Elucidation of mechanisms and perspectives on therapeutic strategies., PMID:40032137

Effects of Pesticide Exposure on Neuroinflammation and Microglial Gene Expression: Relevance to Mechanisms of Alzheimer's Disease Risk., PMID:40027678

Drugs targeting peroxisome proliferator-activated receptors., PMID:39986646

Effects of PCSK9 inhibitors on cancer, diabetes, and cardiovascular diseases., PMID:39986645

Computational insights into fucoidan-receptor binding: Implications for fucoidan-based targeted drug delivery., PMID:39984116

Ubiquitin protease Ubp1 cooperates with Ubp10 and Ubp12 to revert lysine-164 PCNA ubiquitylation at replication forks., PMID:39964481

Rapid dough making quality analysis of wheat flour using Fourier transform infrared spectroscopy and chemometrics., PMID:39961207

Di-Dang-Tang suppresses ferroptosis in the hippocampal CA1 region by targeting PGK1/NRF2/GPX4 signaling pathway to exert neuroprotection in vascular dementia., PMID:39946772

PK/PD modeling of targeted protein degraders: Charting new waters and navigating the shallows., PMID:39929346

Organochlorine pesticides and epigenetic alternations in unexplained female infertility., PMID:39914792

Modulating the phosphorylation status of target proteins through bifunctional molecules., PMID:39900282

Antimicrobial peptides: An alternative strategy to combat antimicrobial resistance., PMID:39900281

New Approach Methodologies (NAMs) to assess killer whale (Orcinus orca) estrogen receptor alpha (ERα) transactivation potencies by DDTs and their risks., PMID:39892322

Extracellular Vesicles as Tools for Crossing the Blood-Brain Barrier to Treat Lysosomal Storage Diseases., PMID:39860010

Integrative proteomic analysis reveals the potential diagnostic marker and drug target for the Type-2 diabetes mellitus., PMID:39850446

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human DDT Protein, N-His [YHD86501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only